α-Synuclein fibrils subvert lysosome structure and function for the propagation of protein misfolding between cells through tunneling nanotubes | PLOS Biology
Proposed pathogenic mechanisms of α-syn-related Lewy body formation in... | Download Scientific Diagram
A Combined α-Synuclein/Fibril (SynFib) Model of Parkinson-Like Synucleinopathy Targeting the Nigrostriatal Dopamine System - IOS Press
Rapid dissemination of alpha-synuclein seeds through neural circuits in an in-vivo prion-like seeding experiment | Acta Neuropathologica Communications | Full Text
Heparin induces α-synuclein to form new fibril polymorphs with attenuated neuropathology | Nature Communications
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3 | Science
Biomedicines | Free Full-Text | Cellular Models of Alpha-Synuclein Aggregation: What Have We Learned and Implications for Future Study
IJMS | Free Full-Text | The Prion-Like Spreading of Alpha-Synuclein in Parkinson's Disease: Update on Models and Hypotheses
Suppression of abnormal α-synuclein expression by activation of BDNF transcription ameliorates Parkinson's disease-like pathology: Molecular Therapy - Nucleic Acids
Human Recombinant Alpha Synuclein Monomer (SPR-316)
Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies: Cell
Cells | Free Full-Text | Alpha-Synuclein Aggregation Pathway in Parkinson’s Disease: Current Status and Novel Therapeutic Approaches
Antibodies against alpha‐synuclein: tools and therapies - Vaikath - 2019 - Journal of Neurochemistry - Wiley Online Library
Cells | Free Full-Text | Alpha-Synuclein Aggregation Pathway in Parkinson’s Disease: Current Status and Novel Therapeutic Approaches
Upregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease - ScienceDirect
Šašek a syn « Studio DVA divadlo
Frontiers | Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease
Lowering alpha-synuclein as a Therapeutic Strategy for Parkinson's disease: Challenges & Possibilities
Inhibition of synucleinopathic seeding by rationally designed inhibitors | eLife
Akamai Blog | Anatomy of a SYN-ACK Attack
IJMS | Free Full-Text | Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease
The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration | PNAS
Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells | Experimental & Molecular Medicine
alpha Synuclein Monoclonal Antibody (Syn 211) (32-8100)
